Arvaya Healthcare Limited submitted a regulatory disclosure to the Corporate Relations Department of BSE Limited. The disclosure is made pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with applicable SEBI Circulars.
The company explicitly stated that the requirement to provide a Statement of Deviation(s) or Variation(s) in the utilisation of funds under Regulation 32 of the SEBI LODR Regulations is not applicable for the quarter ended 30th September 2026. This indicates that there were no deviations from the stated use of funds or variations from the planned utilization during this period.
The letter was signed by Kaushal Shah, Managing Director (DIN: 02175130), on behalf of the company. It was dated 13th November, 2026, and issued from Pune.